Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Magen, Ori, Waxman, Jacob G., Makov-Assif, Maya, Vered, Roni, Dicker, Dror, Hernán, Miguel A., Lipsitch, Marc, Reis, Ben Y. +2 more·2022·New England Journal of Medicine
DOI 10.1056/nejmoa2201688

Cited by (269)

Items 201–269 of 269

  1. Eight-Month Follow-up After the Third Dose of BNT162b2 Vaccine in Healthcare Workers: The Question of a Fourth Dose
    Sung Hee Lim, Seong Hyeok Choi, Ji Youn Kim, Bora Kim, Han Jo Kim, Se Hyung Kim, Chan Kyu Kim, Seong Kyu Park, Jina Yun · 2023 · Journal of Korean Medical Science
  2. Lessons Learned in Elective Surgeries After 6 Pandemic Waves of SARS‐CoV‐2. A Single European Center Experience
    Alejandra García Botella, Sofía Cristina De la Serna, Leyre López Antoñanzas, Rocío Avellana Moreno, Jana Dziaková, Óscar Cano-Valderrama, Esteban Martín‐Antona, Irene Serrano‐García, Antonio José Torres García · 2023 · World Journal of Surgery
  3. Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and death
    Danyu Y. Lin, Yangjianchen Xu, Yu Gu, Shadia Khan Sunny, Zack Moore, Donglin Zeng · 2024 · International Journal of Infectious Diseases
  4. Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence
    Pedro Pablo España, Idoia Castillo-Sintes, María José Legarreta, Amaia Bilbao‐González, Nere Larrea, María Gascón, Ane Uranga, Amaia Artaraz, Julia García-Asensio, José María Quintana et al. · 2024 · Age and Ageing
  5. Kinetics of Neutralizing Antibodies against Omicron Variant in Vietnamese Healthcare Workers after Primary Immunization with ChAdOx1-S and Booster Immunization with BNT162b2
    Nguyen Van Vinh Chau, Lam Anh Nguyet, Nguyen Thanh Dung, Vo Minh Quang, Nguyen Thanh Truong, Le Mau Toan, Le Manh Hung, Dinh Nguyen Huy Man, Dao Bach Khoa, Nguyễn Thanh Phong et al. · 2022 · American Journal of Tropical Medicine and Hygiene
  6. [Chinese consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases (2023)].
    2023 · PubMed Central
  7. Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination
    Kôji Miyazaki, Toshiharu Fujii, Kikue Mori, Ryuichi Tamimoto, Hirofumi Nagamatsu, Tsutomui Murakam, Yasunori Cho, Shinya Goto, Hidezo Mori · 2023 · Journal of Clinical Medicine
  8. Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort study
    Fredrik Methi, Jon Michael Gran, Morten Valberg, Jonas Minet Kinge, Kjetil Elias Telle, Karin Magnusson · 2023 · BMC Medicine
  9. Effectiveness of a Second COVID-19 Vaccine Booster on All-Cause Mortality in Long-Term Care Facility Residents and in the Oldest Old: A Nationwide, Retrospective Cohort Study in Sweden
    Peter Nordström, Marcel Ballin, Anna Nordström · 2022 · SSRN Electronic Journal
  10. Immune response of primary and booster immunity of SARS-CoV-2 vaccination among patients with chronic liver disease
    Ruixin Song, Chao Yang, Jiayin Wang, Qianqian Li, Jing Chen, Kai Sun, Hongmin Lv, Yankai Yang, Jing Liang, Qing Ye et al. · 2022 · medRxiv
  11. Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
    Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, Weibing Wang, Jie Tian, Xueyao Liang, Ye Yao, Caoyi Xue · 2024 · eLife
  12. Risk Factors for Breakthrough Acute SARS‐CoV‐2 Infections in Fully Vaccinated Individuals: A Case‐Control Study Nested in a Prospective Cohort in Medelln, Colombia
    Olga Hernández, Andrés Felipe Naranjo, Juan José Vélez Cadavid, Gisela de la Rosa Echavez, Sara Moreno‐Bedoya, BLADIMIR ALEJANDRO GIL VALENCIA, Jorge E. Sará Ochoa, Francisco Molina Saldarriaga, A. Melissa Moreno, Laura S. Perez‐Restrepo et al. · 2025 · Journal of Medical Virology
  13. Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant
    Shira Regev‐Sadeh, Rachel Michaelson‐Cohen, Dana Madorksy-Feldman, Eitan Friedman, Shunit Armon, Amalfi Qarawani, Naama Srebnik, Joul Hadad, Vered H. Eisenberg, Yakir Segev · 2026 · JAMA Network Open
  14. Hybrid and Vaccine-Induced Immunity Against SARS-CoV-2 in a Cohort of Hospitalized Patients from the Metropolitan Aburrá Valley, Colombia
    Olga Hernández, Andrés F. Naranjo, Juan J. Vélez-Cadavid, Gisela De La Rosa, Bladimir Gil, A. Melissa Moreno, Laura S. Perez‐Restrepo, Jaime Úsuga, Manuela Aristizabal-Valencia, Francisco Molina Saldarriaga et al. · 2026 · Vaccines
  15. Characteristics and Vaccine Booster Effectiveness in Covid-19 Infections Using 15 Days Post-Booster Period as Baseline during the Omicron Wave in A General Medicine office in Toledo (Spain)
    José Luis Turabián · 2022 · General medicine and Clinical Practice
  16. The pros and cons of the second booster dose of the COVID-19 vaccine
    Ehsan Mostafavi · 2022 · Iranian Journal of Microbiology
  17. Structural Exposition of Concern and Belief of COVID-19 Vaccination Knowledge in Ghana
    Oluwafemi Samson Balogun, Sunday Adewale Olaleye, Frank Adusei Mensah, Richard Osei Agjei, Toluwalase Janet Akingbade · 2023 · Advances in healthcare information systems and administration book series
  18. Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung
    Felicitas Kuehne, Lára R. Hallsson, Marjan Arvandi, Sibylle Puntscher, Beate Jahn, Gaby Sroczynski, Uwe Siebert · 2023 · Prävention und Gesundheitsförderung
  19. Using artificial intelligence algorithms to predict the overall survival of hemodialysis patients during the COVID-19 pandemic: A prospective cohort study
    Shao-Yu Tang, Tz‐Heng Chen, Ko‐Lin Kuo, Jue-Ni Huang, Chen-Tsung Kuo, Yuan-Chia Chu · 2023 · Journal of the Chinese Medical Association
  20. Dynamic Antibody Response and Hybrid Immunity Following Multiple COVID-19 Vaccine Doses and Infection: A Case Study
    Sitthichai Kanokudom, Nungruthai Suntronwong, Thaneeya Duangchinda, Nasamon Wanlapakorn, Yong Poovorawan · 2023 · Cureus
  21. Clinical features in patients with COVID-19 treated with biologics for severe asthma
    Takanori Numata, Keitaro Okuda, Hanae Miyagawa, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara, Jun Araya · 2024 · Journal of Allergy and Clinical Immunology Global
  22. Statistical Assessment of the Effectiveness of Multiple COVID-19 Vaccinations on Daily Confirmed Cases in Seoul City
    Jiwoo Kim, Hyosoon Jung · 2024 · Cureus
  23. Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose
    Avi Magid, Khetam Hussein, Halima Dabaja‐Younis, Moran Szwarcwort‐Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Netanel A. Horowitz et al. · 2024 · Antibodies
  24. Risk and protective factors for coronavirus disease 2019 (COVID-19) in allergic rhinitis patients: a national survey in China
    Xiaozhe Yang, Yutong Sima, Jinming Zhao, Jing Zhang, Xiangdong Wang, Luo Zhang · 2024 · Frontiers in Allergy
  25. Statistical Analysis of Multiple Vaccine Effectiveness Against COVID-19 Variants: Integrating Immune Response Dynamics
    Jiwoo Kim, Hyosoon Jung · 2024 · Cureus
  26. COVID-19 vaccination and utility of booster dose: A community-based cross-sectional study
    Geeta Yadav, Himanshu R. Dandu, Hardeep Singh Malhotra, Amita Jain, Shruti Radera, Vikasendu Agrawal, Anil Kumar Verma, Ravi Prakash, Shailendra Singh Yadav, Neeraj Kumar et al. · 2025 · Vaccine
  27. Effectiveness of fourth dose of COVID-19 vaccine against the Omicron variant compared with no vaccination
    Jessie Zeng, Joshua Szanyi, Tony A Blakely · 2022 · International Journal of Epidemiology
  28. UB-612 Multitope Vaccine Targeting SARS-CoV-2 Spike and Non-Spike Proteins Provides Broad and Durable Immune Responses
    Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, Hope Liu, Yu-Hsin Ho, Min-Sheng Wang, Ya-Ting Yang, Po-Yen Chang, Yea-Huei Shen, Kao‐Pin Hwang · 2022 · medRxiv
  29. Virus-like particle displaying SARS-CoV-2 receptor binding domain elicits neutralizing antibodies and is protective in a challenge model
    Julia L. McKechnie, Brooke Fiala, Clancey Wolf, Daniel Ellis, Douglas A. Holtzman, Andrew L. Feldhaus · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Immunologische aspecten van Covid-19-ziekte en van vaccinatie tegen SARS-CoV-2 Deel 1: SARS-CoV-2-immuunantwoord na infectie en vaccinatie
    Johan Fevery, Kai Dallmeier · 2022 · Tijdschrift voor Geneeskunde
  31. Dr. Kitajima et al reply
    Takamasa Kitajima, Atsushi Funauchi, Toshiki Nakajima, Satoshi Marumo, Yoshitaka Imura, Motonari Fukui · 2022 · The Journal of Rheumatology
  32. Study of the effects of in‐person attendance at academic conferences on the health of the attendees under COVID ‐19 pandemic
    Hideaki Yahata, Kiyoko Kato, Mototsugu Shimokawa, Keiko Kawamura, Nobuyuki Shimono, Kei Kawana, Aikou Okamoto, Daisuke Aoki, Tadashi Kimura · 2023 · Journal of obstetrics and gynaecology research
  33. Evidence of vaccination burnout towards multiple shots of COVID-19 vaccines in China (Preprint)
    Caijun Sun, Xueying Fan, Fan Wu, Yangguo Zhao, Bing Lang, Wangmu Duoji, Shiqiang Jiang · 2023
  34. Assessment of antibody titer and side effects after fourth doses of COVID-19 mRNA vaccination in 38 healthy volunteers
    Rikei Kozakai, Susumu Suzuki, Yuri A. Sato, Mizue Takahashi, Nodoka Chida, Mei Takahashi, Kuniko Hoshi, Shinichiro Takahashi · 2023 · Journal of Laboratory Medicine
  35. The persistence and effect of COVID-19 vaccination on the risk of clinical sequelae one year after COVID-19 infection: a territory-wide cohort study in Hong Kong
    Ian Chi Kei Wong, Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, Carlos King Ho Wong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Esther W. Chan, Chak Sing Lau et al. · 2023 · Research Square
  36. Differences in clinical and laboratory characteristics in patients infected with COVID-19 during different epidemic waves
    Aleksandra M. Barac, Aleksa Despotović, Ankica Vujović, Teodora Cucanić, Ksenija Cucanić, Ana Mitić, Mihailo Stjepanović, Nikola Marić, Ana Filipović, Jelena Vlasković et al. · 2023 · Medicinska istrazivanja
  37. Investigating the Epidemiological Trend of COVID-19 Disease in Kohgiluyeh and Boyer Ahmad Province, Iran
    A Mousavizadeh, M behnampur, Roya Alaei, Hasan Askarpour, S darabi, H faghihi · 2023 · Armaghane Danesh
  38. A Scoping Review of Real-World Study in Vaccine Evaluation
    Lei Wang, Hong Yang, Lanfang Xia, Quanwei Song, Na Liu, Guomin Zhang, Fuzhen Wang, Huaqing Wang · 2024 · China CDC Weekly
  39. Older subjects and immunogenicity of mRNA COVID-19 vaccines
    Piotr Seiffert, Dorota Religa · 2024 · Elsevier eBooks
  40. Vaccination against COVID-19 in a post-pandemic era
    Felippe Lazar Neto, Adrián Ceccato, Otavio Ranzani · 2024 · European Respiratory Society eBooks
  41. Enfrentamento à Covid longa e pandemia da Covid 19: um relato de experiência de um projeto de educação em saúde realizado no município de Divinópolis-MG
    Adriano Guimarães Parreira, Ana Carolina Oliveira, Pedro Augusto Assis Souza Avelar · 2023 · Experiência Revista Científica de Extensão
  42. Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in Shanghai
    Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, Weibing Wang, Jie Tian, Xueyao Liang, Ye Yao, Caoyi Xue · 2024 · eLife
  43. Antibody response to SARS-CoV-2 natural and breakthrough infection in patients undergoing maintenance hemodialysis: A prospective cohort study over 4 months
    Yingji Chen, Xiaming Zhang, Mi Zhou, Ping Wu, Juzhen Yan, Chen Sun, Yinghong Zhang, Xiaoyin Zheng · 2024 · Heliyon
  44. Clinical characteristics and booster vaccine effectiveness of the Omicron variant
    Lijun Sun, Biye Zhou, Yijia Guo, Yunfei Huang, Zihui Tang, Zhaojun Wu, Yuwei Li, Liping Zhao, Yi Shan, Xiaolong Xu et al. · 2024 · BMC Infectious Diseases
  45. Evaluation of sars-cov-2 antibody decay over time following booster dose administration: A prospective observational study
    S. Rahman, Rasheda Yasmin Rimi, Tasnim Tabassum Progga, Khaleda Nusrat, Fouzia Sultana, Aaysha Siddiqua, Forhadul Hoque Mollah · 2024 · International Journal of Clinical Biology and Biochemistry
  46. Decaying of SARS-CoV-2 Antibodies with Time after Taking Booster Dose among the Doctors of Bangabandhu Sheikh Mujib Medical University
    S. Rahman, Hasnat Muhammed Arefin, Khaja Badruddza, Shahriar Habib, Tahmidul Islam, Mohammad Masum Alam, Forhadul Hoque Mollah · 2024 · Scholars Journal of Applied Medical Sciences
  47. Efektivitas Vaksin COVID-19 mRNA Booster Kedua pada Tenaga Kesehatan di Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo dan Faktor yang Memengaruhinya
    Siti Taqwa Fitria Lubis, Sukamto Koesnoe, Evy Yunihastuti, Hamzah Shatri, Teguh H. Karjadi, Kuntjoro Harimurti, Ceva Wicaksono Pitoyo, Em Yunir · 2024 · Jurnal Penyakit Dalam Indonesia
  48. eLife assessment: Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
    Joshua Tisdell Schiffer · 2025 · eLife
  49. Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023
    Veerle Stouten, Izaak Van Evercooren, Catharina Vernemmen, Toon Braeye, Lucy Catteau, Mathieu Roelants, Matthieu Billuart, Thomas Lamot, Natalia Bustos Sierra, Naïma Hammami et al. · 2025 · Vaccine
  50. A systematic review and meta-analysis of risk factors for long COVID
    Kensuke Nakagawara, Shiro Otake, Nobuyuki Horita, Ho Namkoong, Hideki Terai, Ryo Takemura, Kengo Nagashima, Shotaro Chubachi, Koichi Fukunaga · 2025 · Research Square
  51. Efficacy and Safety of Influenza and COVID-19 Vaccines
    Naoki Kawai, Hideyuki Ikematsu, Takuma Bando · 2025 · Kansenshogaku zasshi
  52. A nationwide analysis of emergency medical services’ responses during six waves of COVID-19
    Evan Avraham Alpert, Maximilian P. Nerlander, Bezalel Eliav, Ari Moshe Lipsky, Ziv Dadon, Roman Sonkin, Eli Jaffe · 2025 · Journal of Public Health Research
  53. A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity
    Constanza Méndez, Linmar Rodríguez‐Guilarte, Pablo A. Palacios, Cristián Gutiérrez-Vera, Francisca Román, Daniela Moreno‐Tapia, Mariana Ríos, Antonia Reyes, Felipe A. Cancino, Francisco F. Otero et al. · 2025 · BMC Medicine
  54. Additional file 1 of SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
    Xiaohui Jing, Menglin Han, Wang, Xiaoxuan, Zhou, Li · 2023 · Figshare
  55. Additional file 1 of Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort study
    Fredrik Methi, Jon Michael Gran, Morten Valberg, Kinge, Jonas Minet, Kjetil Elias Telle, Karin Magnusson · 2024 · Figshare
  56. Additional file 2 of Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
    Yun Yin, Liu, Yuanhua, Mengwei Duan, Xiyang Xie, Jie Hong, Huang, Jiaqi, Li, Ke, Jin Shi, Xi Chen, Guo, Hongyan et al. · 2023 · Figshare
  57. Additional file 1 of Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
    Yun Yin, Yuanhua Liu, Mengwei Duan, Xiyang Xie, Jie Hong, Huang, Jiaqi, Li, Ke, Jin Shi, Xi Chen, Guo, Hongyan et al. · 2023 · Figshare
  58. Identifying factors associated with acceptance of the fourth COVID-19 vaccine dose: A multicentre cross-sectional study in Indonesia
    Muh. Akbar Bahar, Abdul Rafik Mohi, Ikhwan Yuda Kusuma, Dezső Csupor, MUH. NASRUM MASSI · 2026 · Vaccine X
  59. COVID-19 vaccine policy: a response and way forward
    Gregory A. Poland, Tamar Ratishvili, Peter J. Pitts · 2026 · Vaccine
  60. Risk factors associated with COVID-19 infection among Chinese elite athletes during overseas training and competitions: a large-scale cross-sectional survey
    Jun Chen, Jing Li, Lianmei Jin, Qirong Wang · 2026 · Frontiers in Public Health
  61. Émulation d'essais randomisés à partir de données observationnelles : revue méthodologique et applications
    Noémie Simon‐Tillaux · 2024
  62. Assessing the Impact of Vaccination Strategies on COVID-19 Dynamics Via Time-varying Copulas
    Atina Ahdika, Muhammad Fakhruddin, Putu Veri Swastika · 2026 · Acta Biotheoretica
  63. Clinical Outcomes, Inflammatory Profile, Bacterial Co-Infections and Post-Acute Symptom Burden in Hospitalised COVID-19 Patients During the Omicron BA.5 Wave: A Single-Centre Cohort Study from Western Romania
    Bogdan Adrian Manta, Diana-Maria Mateescu, Stela Iurciuc, Cris Virgiliu Precup, Camelia Corina Pescaru, Alina Andreea Tischer · 2026 · Microorganisms
  64. All-cause mortality patterns according to vaccination timing and dose number among Japanese non-elderly adults: a proxy risk-group analysis
    Hideki Kakeya, Hiroshi Kusunoki, Yumi Watanabe, Ryota Sakai · 2026 · Research Square
  65. SARS-CoV-2 Vaccines Beyond the Pandemic Era, volume II
    2026 · Frontiers research topics
  66. Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant
    Chen Nahshon, Leen Fahoum, Dana Hadar, Hila Cohen, Rachel Michaelson‐Cohen, Shira Regev‐Sadeh, Meirav Schmidt, Wisam Assaf, Steven Alexander Narod, Yakir Segev · 2026 · Breast Cancer
  67. A primer on target trial emulation for respiratory research
    Anthony Justin Gilding, Cristina Longo · 2026 · European Respiratory Journal
  68. Relative efficacy, safety and immunogenicity of bivalent versus monovalent COVID-19 mRNA booster vaccines: a randomized trial
    Sufia S. Dadabhai, Taraz Samandari, Bo Zhang, Aaron Hudson, Nonhlanhla N. Mkhize, Asa Tapley, Jessica G. Andriesen, Penny Moore, Zvavahera Mike Chirenje, Peter Elyanu et al. · 2026 · Research Square
  69. Booster dose of COVID-19 vaccine and its effectiveness against post COVID-19 condition in individuals with pre-existing immunity: a sequential propensity score-matched cohort study
    Lisa Lundberg, Erik Bülow, Huiqi Li, Yiyi Xu, Magnus Gisslén, Fredrik Nyberg, Maria Bygdell · 2026 · EClinicalMedicine